NCT07097987View on ClinicalTrials.gov

Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion

NANot yet recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

WM formula Group

Participants in the intervention group will consume a single dose of WM formula drink (50 mL) on the study day. The formula includes Bifidobacterium breve (probiotic), ClpB formula (prebiotic), and Rocket Apple extract. The ClpB formula consists of kombucha, soy peptide powder, L-arabinose and erythritol.

OTHER

Control group

Participants in the control group will consume 50 mL water

Trial Locations (1)

Unknown

TCI Co., Ltd., Taipei

All Listed Sponsors
lead

TCI Co., Ltd.

INDUSTRY

NCT07097987 - Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion | Biotech Hunter | Biotech Hunter